[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories (CRL)

Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

Collaboration aligns with Charles River’s strategic commitment to building deeper client relationships and accelerating development with alternative methods

ALA : 24.48 (+0.70%)
CRL : 233.41 (-0.08%)
3 Overrated Stocks We’re Skeptical Of

3 Overrated Stocks We’re Skeptical Of

STT : 180.22 (+0.03%)
ETSY : 81.05 (+4.28%)
CRL : 233.41 (-0.08%)
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

CRL : 233.41 (-0.08%)
3 Reasons to Avoid CRL and 1 Stock to Buy Instead

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

CRL : 233.41 (-0.08%)
How Is Charles River Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Despite underperforming its industry peers over the past year, analysts remain highly bullish on Charles River Laboratories' long-term prospects.

XLV : 160.84 (-0.82%)
CRL : 233.41 (-0.08%)
IQV : 207.85 (-0.54%)
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies

CRL : 233.41 (-0.08%)
Stocks Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. June E-mini S&P futures (ESM26...

GOOGL : 357.18 (-0.48%)
AAPL : 315.32 (-0.28%)
ADI : 395.65 (+0.51%)
FDXF : 149.53 (-3.06%)
TSLA : 407.76 (+0.30%)
JBL : 330.29 (-0.67%)
AMD : 557.89 (+2.04%)
CME : 240.27 (+0.23%)
SPY : 754.95 (+0.43%)
META : 669.21 (+5.97%)
MU : 979.30 (-1.24%)
QQQ : 725.51 (+0.31%)
Stocks Supported by Chip Stock Strength and Strong US Retail Sales

The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.74%. June E-mini S&P futures (ESM26...

AMAT : 602.50 (+2.35%)
AVGO : 399.97 (-0.28%)
VZ : 42.12 (-0.28%)
REXR : 34.12 (+0.26%)
$IUXX : 29,825.11 (+0.33%)
WNC : 12.90 (+4.37%)
ASML : 1,797.32 (-0.38%)
ZNU26 : 108-310 (-0.06%)
ESU26 : 7,593.00 (-0.36%)
T : 21.13 (+0.43%)
QCOM : 189.16 (-1.02%)
JBL : 330.29 (-0.67%)
1 S&P 500 Stock on Our Buy List and 2 We Brush Off

1 S&P 500 Stock on Our Buy List and 2 We Brush Off

HCA : 406.59 (-0.59%)
CRL : 233.41 (-0.08%)
CBRE : 139.53 (-1.08%)
Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46 th Annual Growth Stock Conference on Tuesday, June 2 nd ...

CRL : 233.41 (-0.08%)

Barchart Exclusives

Dell Is Winning the AI Infrastructure Race. Here’s What Comes Next After a 250% YTD Rally.
Shares of Dell have risen significantly year-to-date, driven by soaring demand for its AI-optimized servers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.